This is a preview of subscription content, log in via an institution to check access.
References
1. DeMartino P, et al. A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective. JAMA Pediatrics : 22 Mar 2021. Available from: URL: http://doi.org/10.1001/jamapediatrics.2020.7140
2. Ozuah PO. Gene Therapy for Sickle Cell Disease - A Debt to Be Paid. JAMA Pediatrics : 22 Mar 2021. Available from: URL: http://dx.doi.org/10.1001/jamapediatrics.2020.7147
Rights and permissions
About this article
Cite this article
Gene therapy for sickle cell disease: high Medicaid budget impact. PharmacoEcon Outcomes News 875, 10 (2021). https://doi.org/10.1007/s40274-021-7589-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7589-z